Clinical Study Of Fire Acupuncture Combined With Acupoint Injection In Treating Allergic Rhinitis With Deficiency Of Lung And Spleen

Objective: In this study,a randomized controlled method was used,and patients with allergic rhinitis(lung-spleen-qi deficiency)were used as the research object.The treatment was to compare fire needle combined with acupoint injection therapy with oral loratadine tablets,and observe that the two are improving allergies.The main symptoms and signs of the nose of patients with rhinitis and the differences in TCM syndromes are evaluated,and the short-term,medium-and long-term clinical efficacy,safety and recurrence rate are evaluated,hoping to provide more information for enriching the external treatment of Chinese medicine in the treatment of allergic rhinitis.Can refer to the program.Methods: Selected from the acupuncture clinic and ENT ward of Ruikang Hospital affiliated to Guangxi University of Traditional Chinese Medicine who met the inclusion criteria(during December 2019 to December 2020),and were diagnosed with Chinese medicine rhinitis and lung-spleen-qi deficiency.60 cases.According to the method of random number table,60 patients with allergic rhinitis were divided into treatment group and control group,with 30 cases in each group.The treatment group received acupoint injection of fire needle combined with astragalus injection,and the treatment group was treated every two days,five times as a course of treatment,and a total of two courses of treatment;the control group took the western medicine loratadine tablets orally before going to bed,and the dose of each tablet was 10 mg,once a day,fourteen days as a course of treatment,a total of two courses of treatment;two groups of treatment cycles are 28 days.The main symptoms,signs,and changes in the scores of TCM concomitant symptoms are used as observation indicators,and the patient ’ s general information(age,sex,course of disease,history of allergy,etc.)is recorded in detail before treatment.The rhinitis score sheet was filled out before treatment,at the end of treatment,and after 3 months of treatment,and the adverse conditions that occurred during the test were recorded in time,and a database was established for data statistics.After the end of the experiment,through the analysis of the data obtained,the clinical short-term,mid-to-long-term efficacy and clinical adverse reaction rates of the two groups of patients were compared;all patients were followed up on We Chat or telephone 3 months after the end of the treatment to assess the two groups’ performance The recurrence rate situation.Statistically,using SPSS20.0 software,different statistical methods were used to analyze the data results before and after treatment between the two groups and within the two groups.When P<0.05,the difference was statistically significant.Results: 1.There was no statistically significant difference between the two groups of patients in general information such as gender,age,and disease course(all P>0.05),and they were comparable.2.Comparison of clinical total effective rate: After 2 courses of treatment,9 cases in the treatment group were effective,18 cases were effective,and 3 cases were ineffective.The total effective rate in the treatment group was 90.0%;in the control group,0 cases were effective,20 cases were effective,and 10 cases were ineffective,The total effective rate of the control group was 66.7%;after the rank sum test,the difference in clinical efficacy between the two groups was statistically significant(P﹤0.05),and the clinical efficacy of the treatment group was significantly better than that of the control group.3.Comparison of main symptoms,signs and TCM syndrome scores:(1)After 1 month of treatment,the main symptom scores,physical sign scores,and TCM syndrome scores of the observation group and the control group were significantly lower than the scores before treatment(P ﹤ 0.05),the observation is statistically significant,indicating that the two drugs are effective in improving the symptoms of allergic rhinitis;(2)The main symptoms of the two groups(sneezing,runny nose,nasal congestion,nasal itching)were compared between groups It was found that the values of the treatment components were lower than those of the control group,and the difference was statistically significant(P ﹤ 0.05),indicating that the therapeutic effect of the treatment group was better than that of the control group;(3)Before and after treatment,the scores of the turbinate and nasal mucosa of the treatment group were low In the control group,the difference was statistically significant(P﹤0.05);(4)The comparison between the two groups before and after treatment,the total score of the treatment group was significantly lower than the control group,with statistical difference(P ﹤0.05).4.Safety comparison: There were no obvious adverse reactions in the two groups of patients during the treatment.5.Comparison of recurrence rate:After 3 months of treatment,the patients were followed up on We Chat.Of the 30 cases in the treatment group,3 cases relapsed,with a recurrence rate of 10%;among the 30 cases in the control group,13 cases relapsed,with a recurrence rate of 43.3%;suggesting the treatment group The medium and long-term curative effect is better.Conclusion: The short-term,medium-and long-term curative effect of fire needle combined with acupoint injection of astragalus injection in the treatment of allergic rhinitis with deficiency of lung and spleen qi is better than that of oral loratadine tablets alone,and this therapy is more effective Sneeze,runny nose,nasal itching and other nasal symptoms and systemic symptoms have a significant improvement effect,and there are fewer recurrences.It has obvious advantages over the control group and is worthy of clinical promotion.